Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $7.0700 (-16.82%) ($6.5200 - $8.3400) on Thu. Mar. 12, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.15% (three month average) | RSI | 36 | Latest Price | $7.0700(-16.82%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -5.3% a day on average for past five trading days. | Weekly Trend | ANPC declines -8.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) XLB(14%) IPO(13%) LIT(13%) BOTZ(11%) EWJ(11%) | Factors Impacting ANPC price | ANPC will decline at least -3.075% in a week (0% probabilities). SHY(-8%) VIXM(-6%) VXX(-4%) TBT(-2%) TLT(0%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.075% (StdDev 6.15%) | Hourly BBV | 0 () | Intraday Trend | -15.2% | | | |
|
1 - 5 Day Possible Target | $-6.24(-188.26%) | Resistance Level | $9.24 | 5 Day Moving Average | $8.31(-14.92%) | 10 Day Moving Average | $8.76(-19.29%) | 20 Day Moving Average | $9.24(-23.48%) | To recent high | -37.2% | To recent low | 0% | Market Cap | $60m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |